With the continuous breakthrough and application of AI technology, AI is penetrating into all fields and links of the medical industry at an astonishing speed and power, covering AI-assisted diagnosis, AI medical image analysis, AI precision medicine, drug research and development, medical robots and other subdivisions.
In the field of AI health management, Meinian Health, a leading domestic preventive medicine company, has been implementing AI applications since 2017 and has taken the lead in launching a number of attempts.
On April 15, Meinian Health announced that the first domestic health management AI robot jointly developed by it with Huawei Cloud and Runda Medical, the "Healthy Xiaomei" digital intelligent health manager internal beta version, was officially launched. It is reported that Meinian Health will officially release the "Healthy Xiaomei" product at the end of June 2024, and it will be launched for trial in multiple cities at that time.
It is understood that "Healthy Xiaomei" is the core project of Meinian Health's full implementation of the "All in AI" strategy in 2024, and Meinian Health hopes to create a new platform for all-round and full-life cycle digital health management for customers through "Healthy Xiaomei" digital intelligent health managers, effectively improve the efficiency of health prevention and disease management, and bring a new health management experience to individuals and physical examination institutions.
According to the forecast of iResearch, the overall health management market is expected to exceed 3 trillion yuan by 2028, and the compound annual growth rate from 2023 to 2028 is expected to reach 12.5%. Industry insiders pointed out that the products, services and ecological extension of "Healthy Xiaomei" digital intelligent health managers, combined with the rapid development of artificial intelligence technology, will be in an explosive growth track. It is predicted that in the next three years, there will be at least 10 billion business growth space.
The new medical and health ecology behind "treatment-centered" to "health-centered" and "healthy beauty".
According to the analysis of industry insiders, this cooperation with Huawei Cloud and Runda Medical is actually an inevitable choice under Meinian's health development strategy.
Meinian Health is a leading enterprise in the field of preventive medicine, with a large number of big data resources for health examination. More than 600 stores across the country serve 30 million people every year. Since its listing in 2015, Meinian Health has served nearly 200 million people.
As a leading enterprise in the field of preventive medicine, in order to accelerate the strategic implementation of AIGC and large models, Meinian Health has continued to promote ecological cooperation with industry partners and innovation teams at the computing power, model technology and application layer through the "1+1+N" cooperation model in recent years.
It is worth mentioning that the product development process of "Healthy Xiaomei" fully reflects the advantages of Meinian Health in the data side and the R&D side. Throughout the process, Meinian Health uses its massive, accurate and high-quality health examination big data to provide rich data resources for the training and optimization of AI robots. At the same time, Meinian Health has a large team of medical staff, rich medical expert resources, and professional medical knowledge and practical experience to assist in the data labeling, interpretation and testing of health management models.
At the front end of products and services, Meinian Health integrates a mature multidisciplinary expert consultation system, a medical knowledge engine built based on expert clinical experience and medical guidelines, which can provide personalized interpretation of physical examination reports for physical examination customers; Through this project, Meinian Health is committed to optimizing customer experience and meeting customers' all-round and full-cycle health management needs.
Since the 19th National Congress of the Communist Party of China, Healthy China has become a national strategy, "providing all-round and full-cycle health services for the people" has become the work goal, and medical institutions have changed from "treatment-centered" to "health-centered", which has increasingly highlighted the importance of health management.
According to the data of the National Health Commission, the health literacy of Chinese residents has increased from 8.8% in 2012 to 27.78% in 2022.
The core function of "Healthy Xiaomei" digital intelligent health manager can build a full life cycle digital health record for users, and it also has five major functions: "data-driven personalized service, intelligent health management platform, digital twin health management, intelligent auxiliary diagnosis, innovative technology and research and development".
According to Meinian Health, "Healthy Xiaomei" will be gradually promoted and applied to more than 600 physical examination centers across the country under Meinian Health Group. In the future, "Healthy Xiaomei" will also give birth to an innovative ecosystem of services and products, such as smart wearable devices and digital therapeutics, and continuously expand and deepen the application scenarios and service capabilities of products.
With the help of "Healthy Xiaomei" as a new traffic entrance, Meinian Health can make full use of the advantages of large model capabilities and health big data to build an ecosystem with strong AI attributes. And to increase the penetration rate of market customers year by year, but also to transform and increase the existing physical examination scale of Meinian Health.
The "Bian Que System" digital intelligence supports the physical examination of 30 million people, and the "health big data layout" of Meinian has surfaced
At present, AI+healthcare has become one of the most imaginative fields, and with the deep integration of these emerging technologies with healthcare-related fields, it is expected to promote the transformation of the medical industry from "experience-driven" to "data-driven".
According to GMI statistics, the global AI healthcare market exceeded $5.4 billion in 2022 and is expected to reach $70 billion in 2032, with a CAGR of 29.2% in the next decade.
Previously, the 2023 World Artificial Intelligence Conference demonstrated the diversified application scenarios of intelligent healthcare, mainly including remote consultation, remote surgery, remote ultrasound, emergency rescue and other telemedicine applications, in addition to smart guidance, smart hospital management, mobile medical care, AI-assisted diagnosis and treatment and other in-hospital application scenarios.
As a leading enterprise in the field of preventive medicine, Meinian Health has a keen insight into the key role of artificial intelligence technology in industry change, actively conforms to the general trend of intelligent transformation, and began to implement AI applications as early as 2017. Launched in 2017, it is the most popular AI application for AI-assisted diagnosis of pulmonary nodules, which helps accurate screening and improves the quality of physical examinations.
In 2022, Meinian Health Group put forward the strategic goal of "building a new Meinian in three years", and digitalization is the key move. In 2022, Meinian Health Group officially launched the SAAS cloud platform for Bian Que's intelligent physical examination management, and after the Bian Que system was launched, the physical examination of 30 million people was supported by digital intelligence, and the layout of health big data surfaced. This marks that Meinian Health has officially opened the era of a new generation of smart physical examination cloud platform, accelerating the realization of digital and intelligent management of the whole process of physical examination.
Starting from 2022, Meinian Health has begun to provide personalized medical examination services driven by AI algorithm models, and individual customers and group customers can use artificial intelligence technology to customize medical examination packages based on historical data and simple questionnaires.
In 2024, Meinian Health will upgrade from the "All in Digital" strategy to the "All in AI" strategy, and take the R&D and application of artificial intelligence technology as an important strategic development direction of the company.
It can be seen that through a long-term and comprehensive "AI + medical" layout, Meinian Health is striving to upgrade from a leading enterprise in the preventive medical track to a leader in all-round and full-life cycle digital intelligent health management.
It is worth mentioning that with the continuous advancement of Meinian Health's layout in the field of "AI + medical", its own value and core competitiveness are being concerned by the outside world. In the past year, Meinian Health has attracted the attention of a large number of institutional investors and an influx of funds.
According to the statistics of Debang Research Institute, Meinian Health is the top 10 pharmaceutical stocks in the second quarter of 2023 in terms of market capitalization, ranking fifth, with a significant increase of about 115.79% from 1.9 billion yuan in the first quarter to 4.1 billion yuan, and the number of funds held increased to 67.
A number of innovative products have been implemented, and AI helps accurate screening to improve the efficiency of physical examination
At present, the health examination and health management industry is facing many challenges: resource bottlenecks in the traditional mode are becoming increasingly prominent, data utilization needs to be improved, service models are in urgent need of innovation and breakthroughs, and the level of personalized health management needs to be improved.
As a leading enterprise in the field of preventive medicine in China, in recent years, Meinian Health has continued to launch innovative high-quality physical examination programs through the combination of big data and artificial intelligence technology, and has deployed innovative products such as intelligent screening for stomach health, lung health screening, brain health screening, intestinal health screening, and mental health services.
At the same time, Meinian Health uses the combination of big data of health examination and AI artificial intelligence to improve the accuracy of early disease screening, and has achieved core breakthroughs in AI-assisted automatic identification and classification of nail and breast nodules, AI-assisted chest CT reading, ultrasound process automation, and remote quality control of inspection products.
At present, with differentiated products such as Brain Ruijia and Lung Jiening, Meinian Health has established unique product advantages and technical barriers.
Through the lung health screening product "Lung Ning", Meinian Health has established a full-chain lung health risk protection system for customers, from early screening of pulmonary nodules, to early diagnosis of pulmonary nodules, follow-up management, lung cancer diagnosis and treatment intervention, and healthy lifestyle shaping, and has created an innovative management model for the whole process of lung cancer prevention and treatment.
In September 2022, Meinian Health released the first multi-dimensional brain health risk intelligent assessment product - "Brain Ruijia". As of December 31, 2023, "Brain Ruijia" has landed in more than 400 branches of Meinian Health, covering more than 200 cities across the country. After three years of layout, Meinian Health has become a leader and popularizer of early screening for brain diseases such as Alzheimer's disease.
In addition, there are also innovative products of Meinian Health TCM intelligent physical examination. As early as July 2017, Meinian Health launched the TCM Health Examination Standard Project to create a closed-loop health management of integrated Chinese and Western medicine and a forward-looking layout of the chronic disease prevention system. Compared with the traditional mature Western medicine system, traditional Chinese medicine has more advantages in the acceptance of the people, and combined with new models and new technologies, the future prospects of traditional Chinese medicine physical examination are broad.
In the past quarter, products such as "Lung Jiening" and "Brain Ruijia" have achieved more than 200% growth. Meinian Health said that in 2024, the revenue of AI specialized and special new products will show a strong growth momentum, and a series of new services will be launched to the market. Specialized and special products such as AI Brain Ruijia, AI Lung Nodules, AI-Coronary Calcium Points, AI-MDT and Digital Cloud Film are expected to achieve rapid revenue growth.
In addition, in order to further expand its business scope and improve service quality, Meinian Health plans to launch heavyweight products and services such as AI precision nutrition and TCM intelligent physical examination in 2024, combined with advanced artificial intelligence technology, to provide customers with more accurate and personalized health management solutions.
Focusing on the corporate vision of "committed to creating and continuously developing a digital health service platform with all aspects and life cycle in China", Meinian Health has given full play to its advantages in medical examination and health big data and artificial intelligence technology. Industry insiders believe that from the attempts and explorations of various means such as building an AI application ecology, deepening industry-university-research cooperation, applying AI technology, and improving operational efficiency, Meinian Health combines scientific and technological content with humanistic care, combines long-termism with comprehensive layout, and also provides a replicable and promotable practice sample for the industry.